Publications:

TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors.

Oncotarget

Amin, Amit Dipak AD; Li, Lingxiao L; Rajan, Soumya S SS; Gokhale, Vijay V; Groysman, Matthew J MJ; Pongtornpipat, Praechompoo P; Tapia, Edgar O EO; Wang, Mengdie M; Schatz, Jonathan H JH

Publication Date: 2016-04-26

Variant appearance in text: ALK: I1171H

PubMed Link: 27009859

Variant Present in the following documents:

• Main text
• oncotarget-07-23715.pdf

View BVdb publication page